All Stories

  1. Vitamin K as an add-on therapy in pyridoxine-dependent epilepsy

    Article • Molecular Therapy, April 2025, Elsevier

    Sander Houten

  2. Odd-chain dicarboxylic acid feeding recapitulates the biochemical phenotype of glutaric aciduria type 1 in mice

    Article • February 2025, openRxiv

    Sander Houten

  3. A case of hyperlysinemia identified by urine newborn screening

    Article • JIMD Reports, October 2023, Wiley

    Sander Houten

  4. Acyl‐CoA dehydrogenase substrate promiscuity: Challenges and opportunities for development of substrate reduction therapy in disorders of valine and isoleucine metabolism

    Article • Journal of Inherited Metabolic Disease, June 2023, Wiley

    Sander Houten

  5. The biochemistry and physiology of long-chain dicarboxylic acid metabolism

    Article • Biochemical Journal, May 2023, Portland Press Ltd.

    Sander Houten

  6. A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients

    Article • Communications Biology, January 2023, Springer Science + Business Media

    Sander Houten

  7. Acyl-CoA dehydrogenase substrate promiscuity limits the potential for development of substrate reduction therapy in disorders of valine and isoleucine metabolism

    Article • November 2022, openRxiv

    Sander Houten

  8. Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1

    Article • Open Biology, September 2022, Royal Society Publishing

    Sander Houten

  9. Functional Versatility of the Human 2-Oxoadipate Dehydrogenase in the L-Lysine Degradation Pathway toward Its Non-Cognate Substrate 2-Oxopimelic Acid

    Article • International Journal of Molecular Sciences, July 2022, MDPI AG

    Sander Houten

  10. Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1

    Article • May 2022, openRxiv

    Sander Houten

  11. The peroxisomal transporter ABCD3 plays a major role in hepatic dicarboxylic fatty acid metabolism and lipid homeostasis

    Article • Journal of Inherited Metabolic Disease, October 2021, Wiley

    Sander Houten

  12. Peroxisomal L-bifunctional Protein Deficiency Causes Male-specific Kidney Hypertrophy and Proximal Tubular Injury in Mice

    Article • Kidney360, September 2021, Wolters Kluwer Health

    Sander Houten

  13. The peroxisomal transporter ABCD3 plays a major role in dicarboxylic fatty acid metabolism

    Article • July 2021, openRxiv

    Sander Houten

  14. Murine deficiency of peroxisomal l-bifunctional protein (EHHADH) causes medium-chain 3-hydroxydicarboxylic aciduria and perturbs hepatic cholesterol homeostasis

    Article • Cellular and Molecular Life Sciences, June 2021, Springer Science + Business Media

    Sander Houten

  15. A mitochondrial long-chain fatty acid oxidation defect leads to uncharged tRNA accumulation and activation of the integrated stress response in the mouse heart

    Article • May 2021, openRxiv

    Sander Houten

  16. Deficiency of peroxisomal L-bifunctional protein (EHHADH) causes male-specific kidney hypertrophy and proximal tubular injury in mice

    Article • March 2021, openRxiv

    Sander Houten

  17. Murine deficiency of peroxisomal L-bifunctional protein (EHHADH) causes medium-chain 3-hydroxydicarboxylic aciduria and perturbs hepatic cholesterol homeostasis

    Article • March 2021, openRxiv

    Sander Houten

  18. Dietary restriction in the long-chain acyl-CoA dehydrogenase knockout mouse

    Article • December 2020, openRxiv

    Sander Houten

  19. Glutaric aciduria type 3 is a naturally occurring biochemical trait in inbred mice of 129 substrains

    Article • November 2020, openRxiv

    Sander Houten

  20. Deletion of 2‐aminoadipic semialdehyde synthase limits metabolite accumulation in cell and mouse models for glutaric aciduria type 1

    Article • Journal of Inherited Metabolic Disease, July 2020, Wiley

    Sander Houten

  21. Structure–function analyses of the G729R 2-oxoadipate dehydrogenase genetic variant associated with a disorder of l-lysine metabolism

    Article • Journal of Biological Chemistry, June 2020, Elsevier

    Sander Houten

  22. Slc22a5 haploinsufficiency does not aggravate the phenotype of the long‐chain acyl‐CoA dehydrogenase KO mouse

    Article • Journal of Inherited Metabolic Disease, December 2019, Wiley

    Sander Houten

  23. DHTKD1 and OGDH display in vivo substrate overlap and form a hybrid ketoacid dehydrogenase complex

    Article • May 2019, openRxiv

    Sander Houten

  24. Saccharopine, a lysine degradation intermediate, is a mitochondrial toxin

    Article • Journal of Cell Biology, January 2019, Rockefeller University Press

    Sander Houten

  25. Metabolic crosstalk between organelles

    Article • The FASEB Journal, December 2018, Federation of American Societies For Experimental Biology (FASEB)

    Sander Houten, Sai Kocherlakota

  26. News and views

    Article • Journal of Inherited Metabolic Disease, February 2018, Springer Science + Business Media

    Sander Houten

  27. Deficiency of the Mitochondrial NAD Kinase Causes Stress-Induced Hepatic Steatosis in Mice

    Article • Gastroenterology, January 2018, Elsevier

    Sander Houten

  28. Changes in the Metabolome in Response to Low-Dose Exposure to Environmental Chemicals Used in Personal Care Products during Different Windows of Susceptibility

    Article • PLOS One, July 2016, PLOS

    Dr Alberto Sánchez Guijo, Sander Houten

  29. In vivomouse myocardial31P MRS using three-dimensional image-selectedin vivospectroscopy (3D ISIS): technical considerations and biochemical validations

    Article • NMR in Biomedicine, August 2015, Wiley

    Sander Houten

  30. Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism

    Article • AJP Endocrinology and Metabolism, August 2015, American Physiological Society

    Sander Houten

  31. Corrigendum

    Article • Experimental Biology and Medicine, July 2015, SAGE Publications

    Sander Houten

  32. Novel, Compound Heterozygous, Single-Nucleotide Variants inMARS2Associated with Developmental Delay, Poor Growth, and Sensorineural Hearing Loss

    Article • Human Mutation, April 2015, Wiley

    Sander Houten

  33. Fiber-type-specific sensitivities and phenotypic adaptations to dietary fat overload differentially impact fast- versus slow-twitch muscle contractile function in C57BL/6J mice

    Article • The Journal of Nutritional Biochemistry, February 2015, Elsevier

    Sander Houten

  34. Cholesterol-Induced Hepatic Inflammation Does Not Underlie the Predisposition to Insulin Resistance in Dyslipidemic Female LDL Receptor Knockout Mice

    Article • Journal of Diabetes Research, January 2015, Hindawi Publishing Corporation

    Sander Houten

  35. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids

    Article • The Journal of Nutritional Biochemistry, December 2014, Elsevier

    Sander Houten

  36. Pioglitazone treatment restoresin vivomuscle oxidative capacity in a rat model of diabetes

    Article • Diabetes Obesity and Metabolism, October 2014, Wiley

    Sander Houten

  37. SUMOylation-Dependent LRH-1/PROX1 Interaction Promotes Atherosclerosis by Decreasing Hepatic Reverse Cholesterol Transport

    Article • Cell Metabolism, October 2014, Elsevier

    Sander Houten

  38. Bile acids alter male fertility through G-protein-coupled bile acid receptor 1 signaling pathways in mice

    Article • Hepatology, September 2014, Wolters Kluwer Health

    Sander Houten

  39. Multilayered Genetic and Omics Dissection of Mitochondrial Activity in a Mouse Reference Population

    Article • Cell, September 2014, Elsevier

    Sander Houten

  40. A Mitochondrial Expatriate: Nuclear Pyruvate Dehydrogenase

    Article • Cell, July 2014, Elsevier

    Sander Houten

  41. Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, July 2014, Elsevier

    Sander Houten

  42. In vivo proton T1relaxation times of mouse myocardial metabolites at 9.4 T

    Article • Magnetic Resonance in Medicine, June 2014, Wiley

    Sander Houten

  43. Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia

    Article • Human Molecular Genetics, May 2014, Oxford University Press (OUP)

    Sander Houten

  44. Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2014, Endocrine Society

    Sander Houten

  45. Optimizing anesthetic regimen for surgery in mice through minimization of hemodynamic, metabolic, and inflammatory perturbations

    Article • Experimental Biology and Medicine, March 2014, SAGE Publications

    Sander Houten

  46. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models

    Article • The FASEB Journal, March 2014, Federation of American Societies For Experimental Biology (FASEB)

    Sander Houten

  47. Aberrant protein acylation is a common observation in inborn errors of acyl-CoA metabolism

    Article • Journal of Inherited Metabolic Disease, February 2014, Springer Science + Business Media

    Sander Houten

  48. Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation

    Article • Human Molecular Genetics, February 2014, Oxford University Press (OUP)

    Sander Houten

  49. Identification and characterization of Eci3, a murine kidney-specific  3, 2-enoyl-CoA isomerase

    Article • The FASEB Journal, December 2013, Federation of American Societies For Experimental Biology (FASEB)

    Sander Houten

  50. Muscle MRI in patients with long-chain fatty acid oxidation disorders

    Article • Journal of Inherited Metabolic Disease, December 2013, Springer Science + Business Media

    Sander Houten

  51. ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies

    Article • Human Molecular Genetics, October 2013, Oxford University Press (OUP)

    Sander Houten

  52. Myocardial energy shortage and unmet anaplerotic needs in the fasted long-chain acyl-CoA dehydrogenase knockout mouse

    Article • Cardiovascular Research, September 2013, European Society of Cardiology

    Sander Houten

  53. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, September 2013, Elsevier

    Sander Houten

  54. Biochemical Competition Makes Fatty-Acid β-Oxidation Vulnerable to Substrate Overload

    Article • PLoS Computational Biology, August 2013, PLOS

    Sander Houten

  55. Impaired amino acid metabolism contributes to fasting-induced hypoglycemia in fatty acid oxidation defects

    Article • Human Molecular Genetics, August 2013, Oxford University Press (OUP)

    Sander Houten

  56. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, June 2013, Elsevier

    Sander Houten

  57. Prevention and reversal of hepatic steatosis with a high-protein diet in mice

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, May 2013, Elsevier

    Sander Houten

  58. Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice

    Article • Journal of Inherited Metabolic Disease, April 2013, Springer Science + Business Media

    Sander Houten

  59. Overexpression of PLIN5 in skeletal muscle promotes oxidative gene expression and intramyocellular lipid content without compromising insulin sensitivity

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, April 2013, Elsevier

    Sander Houten

  60. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines

    Article • The FASEB Journal, January 2013, Federation of American Societies For Experimental Biology (FASEB)

    Sander Houten

  61. Genetic basis of hyperlysinemia

    Article • Orphanet Journal of Rare Diseases, January 2013, Springer Science + Business Media

    Sander Houten

  62. Acylcarnitines

    Article • Diabetes, December 2012, American Diabetes Association

    Sander Houten

  63. Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation

    Article • AJP Endocrinology and Metabolism, December 2012, American Physiological Society

    Sander Houten

  64. Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure

    Article • PLOS One, August 2012, PLOS

    Sander Houten

  65. Functional redundancy of mitochondrial enoyl-CoA isomerases in the oxidation of unsaturated fatty acids

    Article • The FASEB Journal, July 2012, Federation of American Societies For Experimental Biology (FASEB)

    Sander Houten

  66. Characterization of D-3-hydroxybutyrylcarnitine (ketocarnitine): an identified ketosis-induced metabolite

    Article • Metabolism, July 2012, Elsevier

    Sander Houten

  67. Improving the description of metabolic networks: the TCA cycle as example

    Article • The FASEB Journal, June 2012, Federation of American Societies For Experimental Biology (FASEB)

    Sander Houten

  68. Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis

    Article • Scientific Reports, May 2012, Springer Science + Business Media

    Sander Houten

  69. A Diet Rich in Unsaturated Fatty Acids Prevents Progression Toward Heart Failure in a Rabbit Model of Pressure and Volume Overload

    Article • Circulation Heart Failure, May 2012, Wolters Kluwer Health

    Sander Houten

  70. Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids

    Article • Journal of Lipid Research, April 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Sander Houten

  71. Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation

    Article • Journal of Inherited Metabolic Disease, March 2012, Springer Science + Business Media

    Sander Houten

  72. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation

    Article • Metabolism, January 2012, Elsevier

    Sander Houten

  73. Role of Medium- and Short-Chain L-3-Hydroxyacyl-CoA Dehydrogenase in the Regulation of Body Weight and Thermogenesis

    Article • Endocrinology, December 2011, Endocrine Society

    Sander Houten

  74. New Driver for Lipid Synthesis

    Article • Cell, November 2011, Elsevier

    Sander Houten

  75. The metabolic footprint of aging in mice

    Article • Scientific Reports, October 2011, Springer Science + Business Media

    Sander Houten

  76. Fasting-Induced Myocardial Lipid Accumulation in Long-Chain Acyl-CoA Dehydrogenase Knockout Mice Is Accompanied by Impaired Left Ventricular Function

    Article • Circulation Cardiovascular Imaging, September 2011, Wolters Kluwer Health

    Sander Houten

  77. Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, July 2011, Elsevier

    Sander Houten

  78. Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure

    Article • Journal of Biological Chemistry, June 2011, American Society for Biochemistry & Molecular Biology (ASBMB)

    Sander Houten

  79. Post-natal myogenic and adipogenic developmental

    Article • Nucleus, May 2011, Taylor & Francis

    Sander Houten

  80. PARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure

    Article • Cell Metabolism, April 2011, Elsevier

    Sander Houten

  81. Critical assessment of human metabolic pathway databases: a stepping stone for future integration

    Article • BMC Systems Biology, January 2011, Springer Science + Business Media

    Sander Houten

  82. Acyl-CoA Dehydrogenase 9 Is Required for the Biogenesis of Oxidative Phosphorylation Complex I

    Article • Cell Metabolism, September 2010, Elsevier

    Sander Houten

  83. The Effects of Long- or Medium-Chain Fat Diets on Glucose Tolerance and Myocellular Content of Lipid Intermediates in Rats

    Article • Obesity, July 2010, Wiley

    Sander Houten

  84. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results

    Article • Journal of Inherited Metabolic Disease, May 2010, Springer Science + Business Media

    Sander Houten

  85. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation

    Article • Journal of Inherited Metabolic Disease, March 2010, Springer Science + Business Media

    Sander Houten

  86. Effect of Statins on the Viability of Macrophages and Smooth Muscle Cells

    Article • Journal of Cardiovascular Pharmacology, March 2010, Wolters Kluwer Health

    Sander Houten

  87. Glutamine Synthetase in Muscle Is Required for Glutamine Production during Fasting and Extrahepatic Ammonia Detoxification

    Article • Journal of Biological Chemistry, January 2010, American Society for Biochemistry & Molecular Biology (ASBMB)

    Sander Houten

  88. Increased mitochondrial content rescues in vivo muscle oxidative capacity in long-term high-fat-diet-fed rats

    Article • The FASEB Journal, December 2009, Federation of American Societies For Experimental Biology (FASEB)

    Sander Houten

  89. Mitochondrial long chain fatty acid β-oxidation in man and mouse

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, August 2009, Elsevier

    Sander Houten

  90. Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism

    Article • Obesity, April 2009, Wiley

    Sander Houten

  91. Muscle acylcarnitines during short-term fasting in lean healthy men

    Article • Clinical Science, April 2009, Portland Press Ltd.

    Sander Houten

  92. Effects of Insulin on Ketogenesis Following Fasting in Lean and Obese Men

    Article • Obesity, February 2009, Wiley

    Sander Houten

  93. Pyruvate dehydrogenase kinase 4 expression is synergistically induced by AMP-activated protein kinase and fatty acids

    Article • Cellular and Molecular Life Sciences, February 2009, Springer Science + Business Media

    Sander Houten

  94. Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-Induced Metabolic Disorders by Enhancing Fat Oxidation

    Article • Cell Metabolism, February 2009, Elsevier

    Sander Houten

  95. A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis

    Article • AJP Endocrinology and Metabolism, January 2009, American Physiological Society

    Sander Houten

  96. Metabolomics: Unraveling the chemical individuality of common human diseases

    Article • Annals of Medicine, January 2009, Taylor & Francis

    Sander Houten

  97. Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-Induced Metabolic Disorders by Enhancing Fat Oxidation

    Article • Cell Metabolism, November 2008, Elsevier

    Sander Houten

  98. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes

    Article • The FASEB Journal, July 2008, Federation of American Societies For Experimental Biology (FASEB)

    Sander Houten

  99. The Glucosylceramide Synthase InhibitorN-(5-Adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin Induces Sterol Regulatory Element-Binding Protein-Regulated Gene Expression and Cholesterol Synthesis in HepG2 Cells

    Article • Journal of Pharmacology and Experimental Therapeutics, June 2008, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Sander Houten

  100. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine

    Article • AJP Gastrointestinal and Liver Physiology, May 2008, American Physiological Society

    Sander Houten

  101. Characterization of l-aminocarnitine, an inhibitor of fatty acid oxidation

    Article • Molecular Genetics and Metabolism, April 2008, Elsevier

    Sander Houten

  102. Peroxisome Proliferator-activated Receptor (PPAR)-2 Controls Adipocyte Differentiation and Adipose Tissue Function through the Regulation of the Activity of the Retinoid X Receptor/PPARγ Heterodimer

    Article • Journal of Biological Chemistry, October 2007, American Society for Biochemistry & Molecular Biology (ASBMB)

    Sander Houten

  103. Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1

    Article • Molecular and Cellular Biology, October 2007, ASM Journals

    Sander Houten

  104. In VivoImaging of Farnesoid X Receptor Activity Reveals the Ileum as the Primary Bile Acid Signaling Tissue

    Article • Molecular Endocrinology, June 2007, Endocrine Society

    Sander Houten

  105. A liver revival featuring bile acids

    Article • Journal of Hepatology, March 2007, Elsevier

    Sander Houten

  106. The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice

    Article • Genes & Development, February 2007, Cold Spring Harbor Laboratory Press

    Sander Houten

  107. Homing in on bile acid physiology

    Article • Cell Metabolism, December 2006, Elsevier

    Sander Houten

  108. Peroxisomes and bile acid biosynthesis

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, December 2006, Elsevier

    Sander Houten

  109. Endocrine functions of bile acids

    Article • The EMBO Journal, March 2006, Wiley

    Sander Houten

  110. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

    Article • Nature, January 2006, Springer Science + Business Media

    Sander Houten

  111. Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency

    Article • Arthritis & Rheumatism, January 2006, Wiley

    Sander Houten

  112. PGC-1α

    Article • Cell, October 2004, Elsevier

    Sander Houten

  113. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

    Article • Journal of Clinical Investigation, May 2004, American Society for Clinical Investigation

    Sander Houten

  114. Peroxisome proliferator-activated receptor-γ: too much of a good thing causes harm

    Article • EMBO Reports, February 2004, Wiley

    Sander Houten

  115. The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts

    Article • Annals of Medicine, January 2004, Taylor & Francis

    Sander Houten

  116. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPARγ hypomorphic mice

    Article • Proceedings of the National Academy of Sciences, November 2003, Proceedings of the National Academy of Sciences

    Sander Houten

  117. Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands

    Article • European Journal of Human Genetics, February 2003, Springer Science + Business Media

    Sander Houten

  118. Regulation of Isoprenoid/Cholesterol Biosynthesis in Cells from Mevalonate Kinase-deficient Patients

    Article • Journal of Biological Chemistry, December 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

    Sander Houten

  119. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept

    Article • Clinical & Experimental Immunology, December 2002, Wiley

    Professor Michael McDermott, Sander Houten

  120. Lack of isoprenoid products raises ex vivo interleukin-1? secretion in hyperimmunoglobulinemia D and periodic fever syndrome

    Article • Arthritis & Rheumatism, October 2002, Wiley

    Sander Houten, Prof Ger T Rijkers

  121. Erratum: Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome

    Article • European Journal of Human Genetics, August 2001, Springer Science + Business Media

    Sander Houten

  122. Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome

    Article • European Journal of Human Genetics, April 2001, Springer Science + Business Media

    Sander Houten

  123. Nonorthologous Gene Displacement of Phosphomevalonate Kinase

    Article • Molecular Genetics and Metabolism, March 2001, Elsevier

    Sander Houten

  124. Biochemical and genetic aspects of mevalonate kinase and its deficiency

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, December 2000, Elsevier

    Sander Houten

  125. Article • Journal of Inherited Metabolic Disease, January 2000, Springer Science + Business Media

    Sander Houten

  126. Article • Journal of Inherited Metabolic Disease, January 2000, Springer Science + Business Media

    Sander Houten

  127. Identification and Characterization of Three Novel Missense Mutations in Mevalonate Kinase cDNA Causing Mevalonic Aciduria, a Disorder of Isoprene Biosynthesis

    Article • Human Molecular Genetics, August 1999, Oxford University Press (OUP)

    Sander Houten

  128. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemiaD and periodic fever syndrome

    Article • Nature Genetics, June 1999, Springer Science + Business Media

    Sander Houten, Prof Ger T Rijkers